Active Ingredients and Antidiabetic Activity of Fenugreek: A Review Article

  • Home
  • Active Ingredients and Antidiabetic Activity of Fenugreek: A Review Article

Active Ingredients and Antidiabetic Activity of Fenugreek: A Review Article

1Saleh Ali Alqadoori, 2Farah Ali Dawood, 3Ali A. Al-fahham
1Department of Medical Laboratory Techniques, Balad Technical Institute, Middle Technical University, Baghdad, Iraq
2Department of Basic Science, College of Dentistry, Mustansiriah University, Baghdad, Iraq
3Corresponding Author, Faculty of Nursing, University of Kufa, Iraq


ABSTRACT:

Fenugreek (Trigonella foenum-graecum) is a plant extensively cultivated in Middle Eastern and South Asian countries where its seeds have been traditionally used as flavoring agents in food and in folk medicine for a variety of ailments, including diabetes. Its active ingredients include proteins, saponins, polyphenols, alkaloids, and flavonoids. Extracts were found rich in different phytoconstituents, such as trigonelline, diosgenin, 4-hydroxyisoleucine, 3-hydroxyisoleucine, fenugreekine, saponins, and alkaloids, of which, 4-hydroxyisoleucine and saponins were focused as bioactive molecules. Fenugreek extracts and ingredients exhibit antioxidant, antidiabetic, hepatoprotective, antihyperlipidemic, antimicrobial, and anti-inflammatory activities. Even though fenugreek is known for its thrombolytic action, antidiabetic and hypocholesterolemic effects are often cited as its most important therapeutic effects. Furthermore, some of the active principles and hypoglycemic activity of fenugreek have been characterized and reported. The present article aims to provide an overview of the active ingredients and antidiabetic activity of fenugreek.

 

REFERENCES :

1) Al Mosawi AJ (2021) The use of fenugreek supplementation in diabetes. Glob J Obes Diabetes Metab Syndr 8(2): 010-013. DOI: 10.17352/2455-8583.000051
2) Al-Habori, M., Raman, A., J. Lawrence, M., & Skett, P. (2001). In Vitro Effect of Fenugreek Extracts on Intestinal Sodium-dependent Glucose Uptake and Hepatic Glycogen Phosphorylase A. ncbi.nlm.nih.gov
3) Gaddam, A., Galla, C., Thummisetti, S., Marikanty, R. K., Palanisamy, U. D., & Rao, P. V. (2015). Role of Fenugreek in the prevention of type 2 diabetes mellitus in prediabetes. Journal of diabetes and metabolic disorders, 14, 74. https://doi.org/10.1186/s40200-015-0208-4
4) Goyal, S., Gupta, N., & Chatterjee, S. (2016). Investigating Therapeutic Potential of Trigonella foenum-graecum L. as Our Defense Mechanism against Several Human Diseases. ncbi.nlm.nih.gov
5) Haxhiraj M, White K, Terry C. (2024) The Role of Fenugreek in the Management of Type 2 Diabetes. International Journal of Molecular Sciences.; 25(13):6987. https://doi.org/10.3390/ijms25136987
6) Kim, J., Noh, W., Kim, A., Choi, Y., & Kim, Y. S. (2023). The Effect of Fenugreek in Type 2 Diabetes and Prediabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. International journal of molecular sciences, 24(18), 13999. https://doi.org/10.3390/ijms241813999
7) Kiss R, Szabó K, Gesztelyi R, Somodi S, Kovács P, Szabó Z, Németh J, Priksz D, Kurucz A, Juhász B, Szilvássy Z. Insulin-Sensitizer Effects of Fenugreek Seeds in Parallel with Changes in Plasma MCH Levels in Healthy Volunteers. Int J Mol Sci. 2018 Mar 8;19(3):771. doi: 10.3390/ijms19030771.
8) Nagulapalli Venkata, K. C., Swaroop, A., Bagchi, D., & Bishayee, A. (2017). A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion. Molecular nutrition & food research, 61(6), 10.1002/mnfr.201600950. https://doi.org/10.1002/mnfr.201600950
9) Neelakantan, N., Narayanan, M., J de Souza, R., & M van Dam, R. (2014). Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials. ncbi.nlm.nih.gov 
10) Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., Shaw, J. E., Bright, D., Williams, R., & IDF Diabetes Atlas Committee (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes research and clinical practice, 157, 107843.
https://doi.org/10.1016/j.diabres.2019.107843
11) Visuvanathan, T., Thian Lung Than, L., Stanslas, J., Yih Chew, S., & Vellasamy, S. (2022). Revisiting Trigonella foenum-graecum L.: Pharmacology and Therapeutic Potentialities. ncbi.nlm.nih.gov

  • Share

Leave a Reply

Your email address will not be published. Required fields are marked *